Clinical Trials Browser

Phase 1 × Prostatic Neoplasms × tazemetostat × Clear all

NCT04846478 2026-05-12

Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC

Phase 1 Active not recruiting

Prostatic Neoplasms